Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 66

Adult ID

Epidemiology & Infection Control

Pediatric ID

Trainee

Transplant
Symposium

39 - How Low Can We Go? Optimizing Duration of Therapy

Thursday, September 30, 2021
3:45 PM - 5:00 PM EDT

    Moderator(s)

  • Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA

    Field Medical Officer
    Centers for Disease Control & Prevention & Einstein/ Montefiore
    New York, NY, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Judith Berger, MD

    Divisional Director Infectious Diseases
    Infectious Diseases
    SBH Health System
    Bronx, NY, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Robert Fowler, MDCM MSc

    Professor of Medicine
    Sunnybrook Health Sciences Centre, ON, Canada

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Sameer Kadri, MD, MS, FIDSA

    Intensivist and Head, Clinical Epidemiology Section, Critical Care Medicine Department
    National Institutes of Health Clinical Center
    Bethesda, Maryland, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Kate Dzintars, PharmD

    Clinical Pharmacy Specialist, Infectious Diseases
    Department of Pharmacy
    The Johns Hopkins Hospital
    Baltimore, Maryland, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Judith Berger, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Robert Fowler, MDCM MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sameer S. Kadri, MD, MS, FIDSA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kate Dzintars, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • review of the recent literature and data to help guide shorter antibiotic courses for urinary tract infections (including pyelonephritis)
  • review of the recent literature and data to help guide shorter antibiotic courses for bacteremia (MRSA and gram-negative)
  • review of the recent literature and data to help guide shorter antibiotic courses for respiratory infections

Presentations:

  • Shorter Treatment for Bacteremia (MRSA and Gram-negative)

    Speaker: Robert Fowler, MDCM MSc – Sunnybrook Health Sciences Centre

  • Shorter Treatment for Respiratory Infections

    Speaker: Sameer S. Kadri, MD, MS, FIDSA – National Institutes of Health Clinical Center

  • Shorter Treatment for Urinary Tract Infections (Including Pyelonephritis)

    Speaker: Kate Dzintars, PharmD – The Johns Hopkins Hospital